Amondys 45® (casimersen)
for Duchenne Muscular Dystrophy

Amondys 45 (casimersen) is a prescription medication for Duchenne muscular dystrophy (DMD) in patients with a genetic mutation treatable by exon 45 skipping. It targets exon 45 of the dystrophin gene to help produce functional dystrophin protein, improving muscle stability and potentially slowing disease progression.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Duchenne Muscular Dystrophy